Skinvisible Revenue, Profits - SKVI Quarterly Income Statement

Add to My Stocks
$0.02 $0.01 (33.33%) SKVI stock closing price Oct 15, 2018 (Closing)

Looking at financial statements, along with the Skinvisible stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis. The income statement gives the investor an understanding of the topline or revenue and bottomline or profit numbers of the company and helps investors evaluate if a company has been growing or not. The income statement for SKVI which shows a YOY revenue decline of 0 is specific to a period of time. Investors typically check YoY or QoQ revenue growth. The Skinvisible profit and loss statement for 2018 Q2 shows a net profit of $-0.4M. Profits for last year was $-. Apart from this an investor should also check Skinvisible assets and Skinvisible free cash flow.

View and download details of revenue and profits for Skinvisible for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q2
Skinvisible Revenues or Net Sales
---------
Cost Of Goods Sold (COGS)---0.01M----0.01M--
Skinvisible Gross Profit
--------0.01M-
Research & Development Expense---------
Selling General & Admin Expense---------
Income Before Depreciation Depletion Amortization-0.12M-0.16M--0.12M-0.29M-0.14M-0.16M-0.18M-0.15M
Depreciation Depletion Amortization---------
Non Operating Income---------
Interest Expense---------
Skinvisible Pretax Income
-0.39M--0.13M-0.55M-0.67M-0.47M-0.48M-0.48M-0.46M
Provision for Income Taxes---------
MinorityInterest---------
Investment Gains Losses---------
Other Income---------
Income Before Extraordinaries & Disc Operations-0.4M--0.13M-0.55M-0.67M-0.48M-0.47M-0.48M-0.46M
Extraordinary Items & Discontinued Operations---------
Skinvisible Profit/ Loss (Net Income)
-0.4M--0.13M-0.55M-0.67M-0.48M-0.47M-0.48M-0.46M
Average Shares used to compute Diluted EPS144.83M139.79M-130.49M130.49M123.88M119.45M117.92M116.21M
Average Shares used to compute Basic EPS144.83M139.79M-130.49M130.49M123.88M119.45M117.92M116.21M
Income Before Nonrecurring Items-0.4M---0.55M-0.67M-0.48M-0.47M-0.48M-0.46M
Income from Nonrecurring Items---------
Skinvisible Earnings Per Share Basic Net
0.000.00-0.00-0.010.000.000.000.00
Skinvisible Earnings Per Share Diluted Net
0.000.00-0.00-0.010.000.000.000.00
EPS Diluted Before Nonrecurring Items0.000.00-0.00-0.010.000.000.000.00
Preferred Dividends Acc Pd---------
Dividends Common0.000.000.00------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

It is very helpful to read a report on Skinvisible stock analysis. An investor must check the following items in an income statement:

  • Topline: A growing topline, as seen from the Skinvisible revenue chart, as isn't the case with Skinvisible indicates a sagging business. One needs to compare the QoQ topline or sales growth of SKVI stock with its peers like CXRXF stock and ORPN stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-0.4M for Skinvisible for 2018 Q2. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called statement of revenue and expense. The SKVI financials along with Skinvisible historical stock prices provide a lot of details about the firm.

Skinvisible Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
5.7
Dividend Yield
0%